Lundbeck Foundation

Overview

The Lundbeck Foundation is a Danish charitable foundation dedicated to advancing brain health through substantial investments in biomedical research. Established in 1954 by Grete Lundbeck, the widow of Hans Lundbeck, the foundation owns approximately 70% of the pharmaceutical company H. Lundbeck A/S, which specializes in treatments for brain diseases. The foundation's mission is to support and expand the activities of the Lundbeck Group and to provide funding for high-quality scientific research, particularly in the field of neuroscience. Each year, the Lundbeck Foundation grants around DKK 500 million to support research within medical and natural sciences, including the world's largest neuroscience research prize, The Brain Prize. This prestigious award recognizes outstanding contributions to brain research and is awarded annually to one or more scientists who have made significant impacts in the field. The foundation's funding supports a wide range of research initiatives, from basic to clinical and epidemiological studies, with a strong emphasis on brain health. The Lundbeck Foundation's investment strategy focuses on responsible and sustainable investments with a long-term perspective, particularly in healthcare enterprises. By maintaining a significant ownership stake in H. Lundbeck A/S, the foundation ensures a clear purpose and governance for the future of the company, while remaining independent. This unique model provides flexibility during prosperous times and stability during economic downturns, fostering confidence and value for researchers, patients, and the communities they serve.

Investment Focus

• Focus on brain health and neuroscience research
• Support for biomedical and health science research in Denmark
• Commitment to high-quality scientific research
• Interest in funding from basic to clinical and epidemiological studies
• Preference for projects with a long-term impact on brain health

Portfolio Companies